News related to Afinitor (Everolimus) and/or conditions it is approved for
FDA OKs New Kids' Dose of Cancer Drug
Source: MedPage Today Product Alert [2012.08.30]
WASHINGTON -- The FDA has approved a pediatric dosage of the cancer drug everolimus (Afinitor Disperz) for the treatment of a rare brain tumor.
New treatment option for nonfunctional neuroendocrine tumours of the lung and gastrointestinal tract
Source: Endocrinology News From Medical News Today [2015.10.28]
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or...